Dexmedetomidine

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

44 Suppliers, 17 USDMF, 6 JDMF, 5 EU WC, 13 KDMF, 18 NDC API, 30 Listed Suppliers

DEVELOPMENTS

36 Drug(s) in Development

36 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

DOSSIERs // Finished Dosage Forms

92 Dossiers, 58 FDA Orange Book, 6 Europe, 13 Canada, 6 South Africa, 9 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INTRAVENOUS - EQ 1MG BASE/10ML (EQ 100MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML), SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 1MG BASE/250ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML), INJECTABLE;INJECTION - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML), INJECTABLE;INJECTION - EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

RELATED EXCIPIENT COMPANIES

Suppliers, 2 Actylis

GLOBAL SALES INFORMATION

4 Finished Drug Prices

4 Finished Drug Prices

MARKET PLACE

19 APIs, 7 DOSSIERS // FDF

PATENTS

58 US Patents, 7 US Exclusivities, 3 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

49 News

49 News

Annual Sales of Dexmedetomidine reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Dexmedetomidine

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

44 Suppliers

17 USDMF

6 JDMF

5 EU WC

13 KDMF

18 NDC API

30 Listed Suppliers

DEVELOPMENTS

36 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Forms

92 Dossiers

58 FDA Orange Book

6 Europe

13 Canada

6 South Africa

9 Listed Dossiers

DRUG PRODUCT COMPOSITION

SOLUTION;INTRAVENOUS - EQ 1MG BASE/10ML (EQ 100MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 400MCG BASE/4ML (EQ 100MCG BASE/ML)

SOLUTION;INTRAVENOUS - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 1MG BASE/250ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML)

INJECTABLE;INJECTION - EQ 200MCG BASE/50ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 400MCG BASE/100ML (EQ 4MCG BASE/ML)

INJECTABLE;INJECTION - EQ 80MCG BASE/20ML (EQ 4MCG BASE/ML)

RELATED EXCIPIENT COMPANIES

Suppliers

2 Actylis

GLOBAL SALES INFORMATION

4 Finished Drug Prices

MARKET PLACE

19 APIs

7 DOSSIERS // FDF

PATENTS

58 US Patents

7 US Exclusivities

3 Health Canada Patents

ANALYTICAL SOLUTION(s)

1 USP Standards

1 Other Ref. Standards

DIGITAL CONTENT

49 News

Dexmedetomidine

Pfizer

Dexmedetomidine Hydrochloride

Precedex

Neurological/Mental Disorders

USD

213

243

213

243

-30

-12%